Xiangyan Ruan

ORCID: 0000-0001-7777-247X · 6 papers in corpus · active 2012-2022

Study types

  • article 3
  • other 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 3
  • infertility 1
  • endometrioma 1
other 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2060961

OBJECTIVE: (1) To characterize the cytokine expression profiles of endometriosis related infertile women in comparison to fertile women with endometriosis; (2) to investigate the correlation of the cytokine levels from different tissues. M…

preprint 2020
·doi:10.21203/rs.2.23689/v1

Abstract Purpose Until now, it is not clear how much total ovarian tissue can be removed without affecting ovarian functions. Aim to investigate impact of stepwise removed ovarian tissue on endocrine hormone levels reflecting ovarian functi…

article 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2018.1549220

Objective: To investigate temporary or long-term changes of AMH after laparoscopic endometrioma cystectomy and its dependency on characteristics of endometriomas.Methods: One hundred and seventy-one women, open-labeled prospective study; fi…

article 2017
·doi:10.1016/j.maturitas.2017.03.066
article 2012
·doi:10.3109/09513590.2012.730572

OBJECTIVES: Dienogest (DNG) is already used in hormone therapy, since recently being also the progestogenic component of the first estradiol based contraceptive pill. Data on breast cancer risk are currently not available. Progesterone rece…

review 2012
Maturitas ·doi:10.1016/j.maturitas.2012.01.018

Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a cyanomethyl instead of an ethinyl group at the C-17 position, which may make the compound elicit fewer hepatic effects than other C-19 nortestosterone derivative…